Background-Pathological studies suggest that calcified coronary nodules are a rare cause of thrombotic events. The frequency, distribution, predictors, and outcomes of calcified nodules have never been described. Methods and Results-After successful stenting in 697 patients (167 female; median age, 58.1 years) with acute coronary syndromes, 3-vessel gray-scale and virtual histology intravascular ultrasound was performed in the proximal-mid segments of all 3 coronary arteries as part of a prospective, multicenter study. On the basis of recent histological validation, an independent core laboratory identified calcified nodules as distinct calcification with an irregular, protruding, and convex luminal surface. Patients were followed up for 3 years (median). Overall, 314 calcified nodules were detected in 250 of 1573 analyzable arteries (185 of 623 patients). Thus, the prevalence of calcified nodules was 17% per artery and 30% per patient. Two or more calcified nodules were detected in 48 coronary arteries (3%) in 76 patients (12%). The calcified nodules were located Ͻ40 mm from the ostium of the coronary artery in 85% of left anterior descending arteries and 86% of left circumflex arteries, whereas calcified nodules within the right coronary arteries were evenly and more distally distributed. Patients with calcified nodules were significantly older and had more plaque volume, more thick-cap fibroatheroma, but fewer nonculprit lesion major adverse events on follow-up. Conclusions-Calcified nodules in untreated nonculprit coronary segments in patients with acute coronary syndromes were more prevalent than previously recognized. Although their distribution mirrored the origin of most thrombotic events, calcified nodules caused fewer major adverse events during 3 years of follow-up. (Circulation. 2012;126:537-545.)
T he majority of acute coronary syndrome (ACS) events are the result of sudden luminal thrombosis, with 55% to 60% due to plaque rupture, 30% to 35% caused by plaque erosion, and a small portion resulting from a calcified nodule, an eruptive, dense, calcified mass often having an irregular surface appearance. 1,2 Intravascular ultrasound (IVUS) provides detailed qualitative and quantitative cross-sectional coronary imaging and has a high sensitivity and specificity for detecting intracoronary calcium. To assess calcified nodules in vivo, a validation study was done using coronary arteries from human autopsied hearts. IVUS detected calcification in 285 frames in 856 pathological slices in 29 coronary arteries (11 left anterior descending [LAD], 5 left circumflex [LCx] , and 13 right coronary [RCA] arteries) in 18 autopsy hearts; 17 (6.0%) were calcified nodules, and 268 (94.0%) were nonnodular calcium by histopathology. Calcified nodules were irregular and protruding with a convex luminal surface. 3 The present analysis uses the 3-vessel IVUS data from the Providing Regional Observations to Study Predictors of Events in the Coronary Tree (PROSPECT) study to determine the frequency, distribution, angiographic appearance, virtual histology (VH)-IVUS appearance, predictors, and outcomes of nonculprit calcified nodules in ACS patients.
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Methods
Study Population
PROSPECT was a multicenter, multimodality imaging study that was performed at 37 sites in the United States and Europe to prospectively identify nonculprit vulnerable plaque after treatment of all culprit lesions in patients presenting with ACS. The primary PROSPECT analysis was reported previously. 4 Briefly, patients had all culprit lesions stented (typically without preintervention IVUS) followed by gray-scale and VH-IVUS imaging of the left main coronary artery and the proximal 6 to 8 cm of all epicardial arteries. Clinical follow-up occurred at 30 days, at 6 months, and then yearly for at least 2 years. The prespecified primary end point was the incidence of major adverse cardiovascular events (the composite of death from cardiac causes, cardiac arrest, myocardial infarction, or rehospitalization resulting from unstable or progressive angina according to the Braunwald Unstable Angina Classification and the Canadian Cardiovascular Society Angina Classification). The primary end point was adjudicated by a clinical events committee that had no knowledge of other patient data and that used original source documents. On the basis of follow-up angiography, major adverse cardiovascular events were further adjudicated as occurring at initially treated sites (culprit lesions) or at previously untreated coronary segments (nonculprit lesions). If follow-up angiography was not performed, the site associated with the event was classified as indeterminate. 4 Patient demographics, coronary risk factors, follow-up visits, and all relevant information were retrieved from the study database. The Institutional Review Board at each institution approved the study, and subjects gave written informed consent.
Coronary Angiography and Subsequent Qualitative Angiographic Analysis
Coronary angiograms were performed in at least 2 orthogonal views after intracoronary nitroglycerin. All angiograms were analyzed at the Angiographic Core Laboratory of the Cardiovascular Research Foundation (New York, NY). Qualitative analysis included thrombus, calcification (moderate or severe), and haziness. [5] [6] [7] The longitudinal extension of each of these morphologies was recorded in relation to the distance from the coronary ostium. Nonculprit lesions were prespecified in the protocol as Ն30% visual diameter stenosis. All 3 epicardial vessels and all Ն1.5-mm-diameter side branches were divided into 29 Coronary Artery Surgery Study (CASS) segments. Each CASS segment was then subdivided into 1.5-mmlong subsegments and analyzed.
Gray-Scale and VH-IVUS Image Acquisition
After successful stenting of the culprit lesions in the 697 patients enrolled in the study, 3-vessel IVUS was performed with a syntheticaperture-array, 20-MHz, 3.2F catheter (Eagle Eye, Volcano Corp, Rancho Cordova, CA) after intracoronary nitroglycerin. The IVUS catheter was advanced distally; the guiding catheter was disengaged; and the IVUS catheter was pulled back to the aorto-ostial junction with an R-100 motorized catheter pullback system at 0.5 mm/s. Because the left main was usually imaged during both LAD and LCx pullbacks, the run with better left main image quality was chosen for analysis. During pullback, gray-scale IVUS was recorded, raw radiofrequency data were captured at the top of the R wave, and reconstruction of the color-coded map by a VH-IVUS data recorder was performed (In-Vision Gold, Volcano Corp). IVUS studies were archived onto CD-ROM or DVD for offline analysis.
Gray-Scale IVUS Analysis
Of the 697 enrolled patients, 660 cases with complete IVUS data were sent to the independent IVUS core laboratory (Cardiovascular Research Foundation) for quantitative and qualitative analyses with validated QCU-CMS (Medis, Leiden, the Netherlands) software for contouring. Initial screening identified 623 patients with gray-scale IVUS images suitable for inclusion in the present analysis. The reasons for exclusion were dark images, too much noise, too short a segment of catheter pullback, or sudden jumping or sticking of the catheter during automatic pullback. In each patient, calcified nodules were classified as single (1 solitary nodule in 1 patient) or multiple (Ն2 nodules in a single vessel or at least 1 nodule in Ն2 vessels). The diagnosis of a calcified nodule required independent review and agreement by 2 authors (Y.X. and A.M.). Interobserver and interobserver variability was examined in a randomly selected number of lesions. Each observer assessed the lesion independently on 2 separate occasions, 3 months apart, with blinding for earlier analysis. Intraobserver and interobserver variability yielded good concordance for the diagnosis of calcium nodule (ϭ0.83 and ϭ0.80, respectively).
When a calcified nodule was identified, the proximal and distal reference segments (the most normal-looking cross sections-ie, maximum lumen with least amount of plaque-within 5 mm proximal or distal to the calcified nodule but before any side branch) were also identified and selected for analysis. Between the proximal and distal reference segments, the slice with the smallest lumen and greatest amount of plaque was chosen as the minimum lumen area (MLA) site. Quantitative analysis included external elastic membrane (EEM), lumen, and plaque plus media (calculated as EEM minus lumen) cross-sectional area (CSA) at the site of the calcium nodule, MLA site, and proximal and distal reference segments. Plaque burden (PB) was calculated as follows: PBϭ(plaqueϩmedia CSA/EEM CSA)ϫ100. The remodeling index at the calcified nodule site and at the MLA site was the EEM divided by the average of the proximal and distal reference EEM. Lumen area stenosis at the calcified nodule site and at the MLA site was defined as 1 minus MLA divided by the average reference lumen CSA. Calcium analysis included calcium location (superficial, mixed, or deep) and maximum arc of calcium.
VH-IVUS Analysis
Of the 623 qualified gray-scale IVUS images, 573 cases had VH data available for analysis. The reasons for unavailable VH-IVUS images were failure to capture VH-IVUS data, too much noise, or segmental loss of VH images. VH-IVUS plaque components were color-coded as dense calcium (white), necrotic core (red), fibrofatty (light green), or fibrous tissue (dark green) and reported as absolute CSA and percentages of total plaque CSA with the use of pcVH 2.1 software (Volcano Corp) and proprietary qVH software (developed and validated at the Cardiovascular Research Foundation). Volumes were calculated with the Simpson rule and reported as total volume and normalized area (volume divided by length). Each lesion was classified by VH-IVUS into 1 of the following 5 phenotypes: (1) VH thin-cap fibroatheroma (VH-TCFA); (2) thick-cap fibroatheroma (ThCFA), divided into noncalcified thick-cap fibroatheroma or calcified thick-cap fibroatheroma, depending on whether the necrotic core did or did not contain superficial dense calcium; (3) pathological intimal thickening; (4) fibrotic plaque; and (5) fibrocalcific plaque. Although a lesion could contain features of Ͼ1 phenotype, in PROSPECT, a hierarchy of lesion phenotype was prespecified such that any fibroatheroma (VH-TCFA or ThCFA) took precedence over any nonfibroatheroma and VH-TCFA took precedence over ThCFA. Typical gray-scale and VH-IVUS pictures of a calcified nodule are shown in Figure 1 .
Coregistration Between Angiogram and IVUS
Gray-scale and VH-IVUS analyses were coregistered to the angiographic roadmap through the use of fiduciary side branches for alignment with interpolation as necessary to account for different length measurements. Nonculprit lesions responsible for late events were identified with the follow-up angiogram; then, the corresponding segments and subsegments were matched side by side to the baseline angiograms and gray-scale and VH-IVUS studies. This methodology has been reported as part of the primary PROSPECT analysis. 4 
Statistical Analysis
Statistical analyses were performed with SAS software, version 9.1.3 (SAS Institute, Cary, NC). Continuous variables were presented as the meanϮSD or medians and interquartile ranges (IQRs); comparisons were conducted by the Student t test or the Kruskal-Wallis test. For comparison between calcium nodule site and the adjacent MLA site, a model with generalized estimating equations approach was used to compensate for any potential cluster effect of multiple calcium nodules in the same vessels or in the same patients. The generalized estimating equations model was developed by use of a working correlation structure of compound symmetry and a 2-level nested cluster effect for patient and vessel within patient using the PROC GENMOD code in SAS; the results are presented as leastsquare means with 95% confidential intervals. Discrete variables were presented as percentages and relative frequencies; comparisons were conducted by 2 statistics or the Fisher exact test as appropriate. Intraobserver and interobserver variability for the diagnosis of calcium nodule was measured by the test of concordance. Threeyear outcomes are displayed as time-to-event curves, summarized by use of Cox regression model and hazard ratios. The proportional hazard assumptions for nonculprit major adverse cardiovascular events were checked by use of the graphical and numeric methods of Lin et al 8 and the Kolmogorov-type supremum test. The P value from the supremum test is 0.08, indicating that proportional hazard assumptions are not being violated. A value of PϽ0.05 was considered statistically significant.
Results
Frequency and Distribution of Calcified Nodules
Among 623 patients with 1573 vessels imaged and qualified for analysis (574 LAD, 480 LCx, and 519 RCA), a total of 314 calcified nodules were detected in 250 arteries in 185 patients. Among these, there were 108 LAD nodules in 95 patients, 78 LCx nodules in 73 patients, and 118 RCA nodules in 82 patients. In addition, there were calcified nodules in the left main coronary artery in 10 patients. Thus, the prevalence of at least 1 calcified nodule was 16% per artery (250 of 1573) and 30% per patient (185 of 623). Overall, 17% of LAD, 15% of LCx, and 16% of RCA contained at least 1 calcified nodule. Two or more calcified nodules were detected in 48 coronary arteries (3%) in 76 patients (12%). Among them, 22 patients had Ͼ1 nodule in a single vessel, and 52 patients had nodules in Ͼ1 vessel. Overall, 3% of LADs, 1% of LCxs, and 5% of RCAs were found to have multiple nodules.
Comparison of Patients With and Without Calcified Nodules
Baseline clinical characteristics comparing 185 patients with at least 1 calcified nodule and 438 patients without any calcified nodules are shown in Table 1 . Patients with at least 1 calcified nodule were significantly older, were more likely to have had prior cardiac interventions, and had better cholesterol profiles as indicated by a higher serum high-density lipoprotein cholesterol level and lower ratio of total cholesterol to high-density lipoprotein. Surprisingly, the frequency of diabetes mellitus, hypertension, smoking, and familial coronary artery disease was statistically similar between the 2 groups. There were also no differences between the group with single nodules and the group Figure 1 . Representative intravascular ultrasound (IVUS) and virtual histology (VH)-IVUS images of a calcified nodule and its adjacent fibroatheroma. Calcified nodule had a convex and irregular (nonsmooth and lumpy) luminal surface (white arrow in the lower row) on IVUS and its corresponding VH-IVUS images (middle row). There was a VH thin-cap fibroatheroma (double white arrows in the middle row) proximal to the calcified nodule with mild plaque burden. Angiographically, no significant abnormality was detected (white arrow).
with multiple calcified nodules in terms of baseline clinical characteristics (data not shown). In addition, there was no significant difference in the rate of calcium nodules per patient among the clinical sites that enrolled patients in PROSPECT.
Angiographic Appearance of Calcified Nodules
Overall, only 35 calcified nodules (11%) had evidence of angiographic moderate calcium, 3 (1%) had angiographic severe calcium, and 19 (6%) had the appearance of angiographic haziness ( Figure 2 ). The remaining 257 calcified nodules (82%) appeared normal on angiography. Patients with calcified nodules had the same number of angiographically calcified lesions as patients without calcified nodules (data not shown).
Qualitative and Quantitative Gray-Scale IVUS Findings of Calcium Nodules
The arc of nodular calcium measured 33.5°(IQR, 32.2-34.8); 91% were superficial and 9% were mixed, but none were only deep (leading edge of calcium closer to the EEM than to the lumen).
In 33% of calcified nodules (105 of 314), there was a branch near the calcified nodule site (47 proximal and 58 distal). The distance between the calcified nodule site and the branch measured 3.0 mm (IQR, 2.9 -3.2).
The EEM CSA, lumen CSA, and remodeling index at the calcified nodule site were significantly larger than at the MLA site (lumen CSA: 8. Overall, 37% (118 of 314) of the calcified nodules were located distal to the MLA site, 55% (172 of 314) were located proximal to the MLA site, and 8% (24 of 314) were at the MLA site. Table 3 shows the location of the calcified nodules relative to the MLA site in the LAD, LCx, and RCA, separately.
Overall, 85% (95 of 114) of the calcified nodules were located within the first 40 mm of the LAD: 28 (25%) within the first 10 mm of the LAD, 28 (25%) from 11 to 20 mm, 20 (18%) from 21 to 30 mm, and 19 (17%) from 31 to 40 mm. The axial distribution of calcified nodules was similar in the LCx: 40% in the first 10 mm, 19% from 11 to 20 mm, 12% from 21 to 30 mm, and 13% from 31 to 40 mm. Conversely, calcified nodules within the RCA were evenly and more distally distributed. This analysis is shown in Figure 3 .
VH-IVUS Appearance of Calcified Nodules
Overall, 276 of 314 calcified nodules had VH data available for analysis. Among them, 116 calcified nodules were contained in lesions classified as a fibroatheroma on the basis of their VH-IVUS appearance using the prespecified hierarchy in which a fibroatheroma took precedence over a nonfibroatheroma and VH-TCFA took precedence over ThCFA. Of the 116 calcium nodule-containing lesions classified as a fibroatheroma, 106 were a calcified ThCFA, 5 were a noncalcified ThCFA, and 5 were a VH-TCFA. Among the 160 calcified nodules that were in lesions not classified as a fibroatheroma, 56% were within lesions that had characteristics of pathological intimal thickening, 40% in fibrotic plaque, and 4% in fibrocalcific plaque. In addition, 82 of 276 calcified nodules had a fibroatheroma within the adjacent segment that was predefined as 5 mm proximal or distal to the calcified nodule: 12 were VH-TCFA, 29 were noncalcified ThCFA, and 41 were calcified ThCFA.
Volumetric IVUS Comparison of Patients With Versus Without Calcified Nodules
The volumetric gray-scale and VH-IVUS analyses of the entire length of all 3 coronary arteries imaged per patient (summing the LM, LAD, LCx, and RCA) are shown in Table  4 . Patients with at least 1 calcified nodule had a larger total 3-vessel volumetric PB on gray-scale IVUS and more ThCFAs, necrotic core, and dense calcium on total 3-vessel volumetric VH-IVUS.
Follow-Up Clinical Outcomes
Independent predictors of nonculprit events on a patient level were calculated by including the predictors previously reported in the main PROSPECT article 4 (insulin-treated diabetes mellitus, prior percutaneous coronary intervention, MLA Ͻ4 mm 2 , VH-TCFA, and PB Ͼ70%) and forcing into the model both a propensity score generated by age, high-density lipoprotein, and ratio of total cholesterol to high-density lipoprotein cholesterol (the variables that were statistically significant in Table 1 ) and the presence of at least 1 calcified nodule per patient versus no calcified nodules. The presence of at least 1 calcified nodule per patient was an independent predictor of freedom from nonculprit events ( Table 5) .
As shown in Figure 4 , there were consistently fewer nonculprit lesion major adverse cardiac events in the calcified nodule group compared with the noncalcified nodule group at the 1-, 2-, and 3-year follow-up. The 3-year cumulative nonculprit lesion major adverse cardiovascular event rates were 7.1% versus 14.2%. Overall, there was no death, cardiac arrest, or myocardial infarction in the calcified nodules group. In the entire PROSPECT study, there were 54 nonculprit events associated with baseline IVUS-imaged lesions, but only 4 were associated with a nonculprit lesion calcified nodule, and they had a VH-TCFA within the same analysis segment and (therefore) were classified as VH-TCFA.
Discussion
In the present study using the 3-vessel IVUS data from PROSPECT, we report the prevalence, distribution, predictors, and outcomes of coronary artery calcified nodules in vivo. The major findings of our analysis are as follows. First, nonculprit calcified nodules were not unusual in patients with ACS; 314 calcified nodules were detected in 1573 arteries in 623 patients. Second, the axial location of calcified nodules was similar to previous reports of the location of plaque rupture, VH-TCFA, and acute coronary thrombosis. 9 -11 Third, calcified nodules were more common in older individuals. Finally, calcified nodules were, surprisingly, associated with fewer events during the 3-year follow-up. MLA indicates minimum lumen cross-sectional area; EEM, external elastic membrane; and CSA, cross-sectional area.
*Generalized estimating equations least mean squares mean (95% confidence interval).
†Corrected incorporating generalized estimating equations methods to account for clustering at the subject level and vessel level. At the MLA site, n (%) 12 (10) 3 (4) 9 (8) LAD indicates left anterior descending artery; LCx, left circumflex artery; RCA, right coronary artery; and MLA, minimum lumen cross-sectional area.
*Overall Pϭ0.10, LAD versus LCx versus CA.
Pathology and IVUS Assessment of Individual Calcified Nodules
The origin of calcified nodules in ACS patient is not precisely known. On histology, this lesion with element of fibrous layer has the greatest amount of calcification relative to plaque area among vulnerable plaque subtypes and is thought to be associated with a healed fibroatheroma and, potentially, frequent intraplaque hemorrhage. 12, 13 To assess calcified nodules in vivo, a calcified nodule validation study was done using coronary arteries from human autopsied hearts. IVUS detected calcification in 285 frames; 17 (6.0%) were calcified nodules and 268 (94.0%) were nonnodular calcium by histopathology. Two calcified nodules (11.8%) were solitary, and 15 (88.2%) were adjacent to nonnodular calcium. IVUS characteristics of calcified nodules were (1) protruding and convex shape of the luminal surface (94.1% in calcified nodule versus 9.7% in nonnodular calcium; PϽ0.001), (2) convex shape of the luminal side of calcium (100% versus 16.0%; PϽ0.001), (3) irregular luminal surface (64.7% versus 11.6%; PϽ0.001), and (4) irregular leading edge of calcium (88.2% versus 19.0%; PϽ0.001). 3 Burke et al 14 observed that healed plaque ruptures were associated with increased calcification and suggested that plaque disruption, via hemorrhage, may contribute to coronary calcification. Each calcified nodule is small, but calcified nodules tend to cluster 13 ; in the present investigation, multiple calcified nodules were observed in 76 of 623 patients (12%), 22 in the same artery.
Culprit calcified nodule has been reported by 1 pathology group to be a rare cause of coronary thrombosis. 12, 13 However, nonculprit calcified nodule may represent precursor lesions similar to thin-cap fibroatheromas; calcified nodules do not often lead to thrombosis (as suggest by the low event rate in the present study), just as thin-cap fibroatheromas do not always result in plaque rupture. Furthermore, in a computed tomographic angiography study, Thilo et al 15 reported that calcified nodules were rarely stenotic, similar to our present report, presumably because neither study evaluated culprit lesions. 
Calcified Nodule as a Marker of Atherosclerosis
Previous pathological studies have shown a correlation between coronary calcium and atherosclerotic plaque volume. 16 Mintz et al 17 reported that the presence and magnitude of target lesion calcium paralleled the atherosclerotic PB as assessed by IVUS. Similarly, Sangiorgi et al 18 reported the relationship between the calcium area and PB (but not luminal stenosis) in a histopathological study of 723 coronary artery segments using nondecalcified methodology. Thus, these studies taken together imply that calcium is a reliable marker for extensive atherosclerosis. In the present study, PB was greater in patients with at least 1 calcified nodule than in patients with no calcified nodules, along with more ThCFAs (but not more VH-TCFAs) and more necrotic core plaque and dense calcium. These findings suggested that calcified nodules might be a marker for atherosclerosis; however, they were associated with fewer future cardiac events, suggesting quiescence rather than ongoing activity.
Axial Distribution of Calcified Nodules
There are no pathology data on the location of nonculprit calcified nodule, Virmani et al 12 reported that culprit calcified nodules were found predominantly in the mid-RCA, where coronary torsion stress was maximal. Interestingly, in the present study, coronary artery calcified nodules occurred in a limited, focal distribution similar to plaque ruptures, acute occlusions, and TCFAs. Calcified nodules in the present study were clustered mainly in the proximal segments of the LAD and LCx, whereas calcified nodules within the RCA were evenly and more distally distributed. In an angiographic study, Wang et al 9 analyzed 208 consecutive patients with ST-segment-elevation myocardial infarction to determine the location of epicardial thrombosis and found that the occlusions tended to cluster within the proximal third of each coronary artery. In a 3-vessel IVUS study, Hong et al 10 evaluated the axial location of plaque rupture in 392 patients. Plaque ruptures occurred mainly in the proximal segments of the LAD, the proximal and distal segments of RCA, and the entire LCx. Cheruvu et al 11 also reported that TCFAs tended to cluster in predictable spots within the proximal third of the major coronary arteries in a pathological study.
Angiographic and VH Features of Calcified Nodule
The angiographic appearance of calcified nodules is not well established. One previous study reported a patient with an intracoronary angiographic filling defect that initially was diagnosed as intraluminal thrombus but whose preintervention IVUS imaging showed that the filling defect was, in fact, superficial calcification consistent with the appearance of a calcified nodule. 19 However, in the present study, calcified nodules were an incidental finding, with 257 (82%) appearing normal on angiography, 38 (14%) having evidence of angiographic calcium, and 19 (6%) having the appearance of angiographic haziness. The reasons for the absence of any angiographic filling defects in the present analysis may be that we studied only nonculprit lesions, the calcium nodules in the present study were relatively small, and angiographic filling defects have been reported in culprit lesions of ACS patients, albeit rarely. The VH-IVUS appearance of calcified nodules has never been reported. On pathology, calcified nodules appeared to be a mixture of calcified plate, bony spicules, and interspersed fibrin. 12 We observed that a calcified nodule itself and its adjacent segment mostly had stable VH phenotype (calcified ThCFA or noncalcified ThCFA). The accuracy of VH-IVUS analysis behind calcium continues to be controversial and probably depends on the thickness, density, and amount of calcium analyzed. Sales et al 20 reported that "adding" calcific elements to the atherosclerotic plaque led to a directly proportional increase in the area coded as necrotic core in VH-IVUS images and influenced the exact measurement of the amount and extent of necrotic core. Thus, in the present investigation, the necrotic core volume in the calcified nodule group might be overestimated by the influence of a greater amount of dense calcium. However, it is interesting to speculate that the presence of stable VH-IVUS lesion morphology may have contributed to the clinical outcomes in the present study.
Calcified Nodules and Cardiac Events
Virmani et al 12 found calcified nodules in sudden coronary death victims and hypothesized that physical forces exerted by the nodules themselves might contribute to fibrous-cap disruption. However, other evidence indicated that calcific plaque may be stabilized as it evolves with decreased hard/ soft interface area and thus less prone to rupture than noncalcified lesions. 21 In the present study, we observed consistently fewer nonculprit lesion major adverse cardiac events in the calcified nodule group compared with the noncalcified nodule group at the 1-, 2-, or 3-year follow-up. More important, there was no death, cardiac arrest, or myocardial infarction in the calcified nodules group. Several explanations are possible. First, calcified nodules were rarely VH-TCFAs; the VH phenotype appearance of calcific nodules has not been associated with increased events. 22, 23 Second, calcified nodules were not associated with an increased frequency of VH-TCFAs elsewhere in the coronary tree, and VH-TCFAs were the only phenotype associated with increased events in PROSPECT. 4 Third, calcified nodules may have been the end result of plaque rupture, thrombosis, and healing rather than being causative of events.
Limitations
The study cohort included nonculprit lesions in ACS patients, it did not include culprit lesions and was not a study of a general patient population. Because vulnerable plaques tend to be clustered, the actual prevalence of calcified nodules might be lower than what we presented. Second, IVUS was performed after culprit lesion intervention; therefore, plaque tissue morphology at the culprit site could not be evaluated for the existence of calcified nodules. Third, pathological study has shown that a calcified nodule may be covered by a thin layer of fibrin or endothelium that is below the resolution of traditional IVUS. However, this should not affect the diagnostic accuracy of IVUS, although it might affect the likelihood that a calcified nodule would cause an event. In the future, tissue characterization of calcified nodules along with any overlying tissue should be detectable with optical coherence tomography. Fourth, the fact that relatively few events occurred during follow-up in the present study-both in patients with and in those without calcified nodules-attests to the benefits of intensive medical therapy in compliant patients and how closely these patients were followed up in this clinical trial (and expertly treated when severe angina did occur). Finally, calcification is a reflector for ultrasound, causing typical acoustic shadowing in the IVUS images. Ultrasound signals cannot penetrate or pass through the calcified layer and are reflected back toward the transducer. Therefore, accurate tissue characterization of the areas beneath calcification such as the interior of the calcified nodules in the present study is not possible as with conventional IVUS. The accuracy of VH-IVUS analysis behind calcium continues to be controversial and probably depends on the thickness, density, and amount of calcium analyzed.
Conclusions
Our findings demonstrated that calcified nodules in human coronary arteries were frequent and focally distributed. They were common in older patients and were unlikely to cause events during a 3-year follow-up.
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CLINICAL PERSPECTIVE
The majority of acute coronary syndrome events are the result of sudden luminal thrombosis, with 55% to 60% caused by plaque rupture, 30% to 35% resulting from plaque erosion, and a small portion due to a calcified nodule. In the present analysis using 3-vessel intravascular ultrasound and virtual histology imaging and comprehensive follow-up data from Providing Regional Observations to Study Predictors of Events in the Coronary Tree (PROSPECT), we describe the frequency of incidentally detected calcified nodules and the angiographic appearance, intravascular ultrasound and virtual histology intravascular ultrasound features, and natural history of patients whose arteries contain Ն1 calcified nodules. The incidence of calcified nodule was 17% per artery and 30% per patient. Two or more calcified nodules were detected in 48 coronary arteries (3%) in 76 patients (12%). The calcified nodules were located Ͻ40 mm from the ostium of the coronary artery in 85% of left anterior descending arteries and 86% of left circumflex arteries, whereas calcified nodules within the right coronary arteries were evenly and more distally distributed, similar to other vulnerable plaque types. Patients with calcified nodules were significantly older and had more plaque volume, more thick-cap fibroatheroma, but fewer events at follow-up that could be attributed to their calcified nodules. Therefore, although a culprit calcified nodule has been reported by 1 pathology group to be a cause (albeit rarely) of coronary thrombosis, incidentally detected nonculprit calcified nodules appear to be more benign and do not often lead to thrombosis as suggested by the low event rate in the present study. T he majority of acute coronary syndrome (ACS) events are the result of sudden luminal thrombosis, with 55% to 60% due to plaque rupture, 30% to 35% caused by plaque erosion, and a small portion resulting from a calcified nodule, an eruptive, dense, calcified mass often having an irregular surface appearance. 1,2 Intravascular ultrasound (IVUS) provides detailed qualitative and quantitative cross-sectional coronary imaging and has a high sensitivity and specificity for detecting intracoronary calcium. To assess calcified nodules in vivo, a validation study was done using coronary arteries from human autopsied hearts. IVUS detected calcification in 285 frames in 856 pathological slices in 29 coronary arteries (11 left anterior descending [LAD], 5 left circumflex [LCx], and 13 right coronary [RCA] arteries) in 18 autopsy hearts; 17 (6.0%) were calcified nodules, and 268 (94.0%) were nonnodular calcium by histopathology. Calcified nodules were irregular and protruding with a convex luminal surface. 3 The present analysis uses the 3-vessel IVUS data from the Providing Regional Observations to Study Predictors of Events in the Coronary Tree (PROSPECT) study to determine the frequency, distribution, angiographic appearance, virtual histology (VH)-IVUS appearance, predictors, and outcomes of nonculprit calcified nodules in ACS patients.
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Methods
Study Population
Coronary Angiography and Subsequent Qualitative Angiographic Analysis
Coronary angiograms were performed in at least 2 orthogonal views after intracoronary nitroglycerin. All angiograms were analyzed at the Angiographic Core Laboratory of the Cardiovascular Research Foundation (New York, NY). Qualitative analysis included thrombus, calcification (moderate or severe), and haziness. [5] [6] [7] The longitudinal extension of each of these morphologies was recorded in relation to the distance from the coronary ostium. Nonculprit lesions were prespecified in the protocol as �30% visual diameter stenosis. All 3 epicardial vessels and all �1.5-mm-diameter side branches were divided into 29 Coronary Artery Surgery Study (CASS) segments. Each CASS segment was then subdivided into 1.5-mmlong subsegments and analyzed.
Gray-Scale and VH-IVUS Image Acquisition
Gray-Scale IVUS Analysis
Of the 697 enrolled patients, 660 cases with complete IVUS data were sent to the independent IVUS core laboratory (Cardiovascular Research Foundation) for quantitative and qualitative analyses with validated QCU-CMS (Medis, Leiden, the Netherlands) software for contouring. Initial screening identified 623 patients with gray-scale IVUS images suitable for inclusion in the present analysis. The reasons for exclusion were dark images, too much noise, too short a segment of catheter pullback, or sudden jumping or sticking of the catheter during automatic pullback. In each patient, calcified nodules were classified as single (1 solitary nodule in 1 patient) or multiple (�2 nodules in a single vessel or at least 1 nodule in �2 vessels). The diagnosis of a calcified nodule required independent review and agreement by 2 authors (Y.X. and A.M.). Interobserver and interobserver variability was examined in a randomly selected number of lesions. Each observer assessed the lesion independently on 2 separate occasions, 3 months apart, with blinding for earlier analysis. Intraobserver and interobserver variability yielded good concordance for the diagnosis of calcium nodule (��0.83 and ��0.80, respectively).
When a calcified nodule was identified, the proximal and distal reference segments (the most normal-looking cross sections-ie, maximum lumen with least amount of plaque-within 5 mm proximal or distal to the calcified nodule but before any side branch) were also identified and selected for analysis. Between the proximal and distal reference segments, the slice with the smallest lumen and greatest amount of plaque was chosen as the minimum lumen area (MLA) site. Quantitative analysis included external elastic membrane (EEM), lumen, and plaque plus media (calculated as EEM minus lumen) cross-sectional area (CSA) at the site of the calcium nodule, MLA site, and proximal and distal reference segments. Plaque burden (PB) was calculated as follows: PB�(plaque�media CSA/EEM CSA)�100. The remodeling index at the calcified nodule site and at the MLA site was the EEM divided by the average of the proximal and distal reference EEM. Lumen area stenosis at the calcified nodule site and at the MLA site was defined as 1 minus MLA divided by the average reference lumen CSA. Calcium analysis included calcium location (superficial, mixed, or deep) and maximum arc of calcium.
VH-IVUS Analysis
Of the 623 qualified gray-scale IVUS images, 573 cases had VH data available for analysis. The reasons for unavailable VH-IVUS images were failure to capture VH-IVUS data, too much noise, or segmental loss of VH images. VH-IVUS plaque components were color-coded as dense calcium (white), necrotic core (red), fibrofatty (light green), or fibrous tissue (dark green) and reported as absolute CSA and percentages of total plaque CSA with the use of pcVH 2.1 software (Volcano Corp) and proprietary qVH software (developed and validated at the Cardiovascular Research Foundation). Volumes were calculated with the Simpson rule and reported as total volume and normalized area (volume divided by length). Each lesion was classified by VH-IVUS into 1 of the following 5 phenotypes: (1) VH thin-cap fibroatheroma (VH-TCFA); (2) thick-cap fibroatheroma (ThCFA), divided into noncalcified thick-cap fibroatheroma or calcified thick-cap fibroatheroma, depending on whether the necrotic core did or did not contain superficial dense calcium; (3) pathological intimal thickening; (4) fibrotic plaque; and (5) fibrocalcific plaque. Although a lesion could contain features of �1 phenotype, in PROSPECT, a hierarchy of lesion phenotype was prespecified such that any fibroatheroma (VH-TCFA or ThCFA) took precedence over any nonfibroatheroma and VH-TCFA took precedence over ThCFA. Typical gray-scale and VH-IVUS pictures of a calcified nodule are shown in Figure 1 .
Coregistration Between Angiogram and IVUS
Statistical Analysis
Statistical analyses were performed with SAS software, version 9.1.3 (SAS Institute, Cary, NC). Continuous variables were presented as the mean�SD or medians and interquartile ranges (IQRs); comparisons were conducted by the Student t test or the Kruskal-Wallis test. For comparison between calcium nodule site and the adjacent MLA site, a model with generalized estimating equations approach was used to compensate for any potential cluster effect of multiple calcium nodules in the same vessels or in the same patients. The generalized estimating equations model was developed by use of a working correlation structure of compound symmetry and a 2-level nested cluster effect for patient and vessel within patient using the PROC GENMOD code in SAS; the results are presented as leastsquare means with 95% confidential intervals. Discrete variables were presented as percentages and relative frequencies; comparisons were conducted by � 2 statistics or the Fisher exact test as appropriate. Intraobserver and interobserver variability for the diagnosis of calcium nodule was measured by the � test of concordance. Threeyear outcomes are displayed as time-to-event curves, summarized by use of Cox regression model and hazard ratios. The proportional hazard assumptions for nonculprit major adverse cardiovascular events were checked by use of the graphical and numeric methods of Lin et al 8 and the Kolmogorov-type supremum test. The P value from the supremum test is 0.08, indicating that proportional hazard assumptions are not being violated. A value of P�0.05 was considered statistically significant.
Results
Frequency and Distribution of Calcified Nodules
Among 623 patients with 1573 vessels imaged and qualified for analysis (574 LAD, 480 LCx, and 519 RCA), a total of 314 calcified nodules were detected in 250 arteries in 185 patients. Among these, there were 108 LAD nodules in 95 patients, 78 LCx nodules in 73 patients, and 118 RCA nodules in 82 patients. In addition, there were calcified nodules in the left main coronary artery in 10 patients. Thus, the prevalence of at least 1 calcified nodule was 16% per artery (250 of 1573) and 30% per patient (185 of 623). Overall, 17% of LAD, 15% of LCx, and 16% of RCA contained at least 1 calcified nodule. Two or more calcified nodules were detected in 48 coronary arteries (3%) in 76 patients (12%). Among them, 22 patients had �1 nodule in a single vessel, and 52 patients had nodules in �1 vessel. Overall, 3% of LADs, 1% of LCxs, and 5% of RCAs were found to have multiple nodules.
Comparison of Patients With and Without Calcified Nodules
Angiographic Appearance of Calcified Nodules
Overall, only 35 calcified nodules (11%) had evidence of angiographic moderate calcium, 3 (1%) had angiographic severe calcium, and 19 (6%) had the appearance of angiographic haziness (Figure 2 ). The remaining 257 calcified nodules (82%) appeared normal on angiography. Patients with calcified nodules had the same number of angiographically calcified lesions as patients without calcified nodules (data not shown).
Qualitative and Quantitative Gray-Scale IVUS Findings of Calcium Nodules
The EEM CSA, lumen CSA, and remodeling index at the calcified nodule site were significantly larger than at the MLA site (lumen CSA: 8. Table 2 ). Of all the calcified nodules analyzed, only 12 (of 314) had an MLA �4 mm 2 , and only 8 had an area stenosis �50%.
Overall, 37% (118 of 314) of the calcified nodules were located distal to the MLA site, 55% (172 of 314) were located proximal to the MLA site, and 8% (24 of 314) were at the MLA site. Table 3 shows the location of the calcified nodules relative to the MLA site in the LAD, LCx, and RCA, separately.
VH-IVUS Appearance of Calcified Nodules
Volumetric IVUS Comparison of Patients With Versus Without Calcified Nodules
Follow-Up Clinical Outcomes
Independent predictors of nonculprit events on a patient level were calculated by including the predictors previously reported in the main PROSPECT article 4 (insulin-treated diabetes mellitus, prior percutaneous coronary intervention, MLA �4 mm 2 , VH-TCFA, and PB �70%) and forcing into the model both a propensity score generated by age, high-density lipoprotein, and ratio of total cholesterol to high-density lipoprotein cholesterol (the variables that were statistically significant in Table 1 ) and the presence of at least 1 calcified nodule per patient versus no calcified nodules. The presence of at least 1 calcified nodule per patient was an independent predictor of freedom from nonculprit events ( Table 5) .
Discussion
†Corrected incorporating generalized estimating equations methods to account for clustering at the subject level and vessel level. 
Pathology and IVUS Assessment of Individual Calcified Nodules
The origin of calcified nodules in ACS patient is not precisely known. On histology, this lesion with element of fibrous layer has the greatest amount of calcification relative to plaque area among vulnerable plaque subtypes and is thought to be associated with a healed fibroatheroma and, potentially, frequent intraplaque hemorrhage. 12, 13 To assess calcified nodules in vivo, a calcified nodule validation study was done using coronary arteries from human autopsied hearts. IVUS detected calcification in 285 frames; 17 (6.0%) were calcified nodules and 268 (94.0%) were nonnodular calcium by histopathology. Two calcified nodules (11.8%) were solitary, and 15 (88.2%) were adjacent to nonnodular calcium. IVUS characteristics of calcified nodules were (1) protruding and convex shape of the luminal surface (94.1% in calcified nodule versus 9.7% in nonnodular calcium; P�0.001), (2) 3 Burke et al 14 observed that healed plaque ruptures were associated with increased calcification and suggested that plaque disruption, via hemorrhage, may contribute to coronary calcification. Each calcified nodule is small, but calcified nodules tend to cluster 13 ; in the present investigation, multiple calcified nodules were observed in 76 of 623 patients (12%), 22 in the same artery.
Culprit calcified nodule has been reported by 1 pathology group to be a rare cause of coronary thrombosis. 12, 13 However, nonculprit calcified nodule may represent precursor lesions similar to thin-cap fibroatheromas; calcified nodules do not often lead to thrombosis (as suggest by the low event rate in the present study), just as thin-cap fibroatheromas do not always result in plaque rupture. Furthermore, in a computed tomographic angiography study, Thilo et al 15 reported that calcified nodules were rarely stenotic, similar to our present report, presumably because neither study evaluated culprit lesions. Previous pathological studies have shown a correlation between coronary calcium and atherosclerotic plaque volume. 16 Mintz et al 17 reported that the presence and magnitude of target lesion calcium paralleled the atherosclerotic PB as assessed by IVUS. Similarly, Sangiorgi et al 18 reported the relationship between the calcium area and PB (but not luminal stenosis) in a histopathological study of 723 coronary artery segments using nondecalcified methodology. Thus, these studies taken together imply that calcium is a reliable marker for extensive atherosclerosis. In the present study, PB was greater in patients with at least 1 calcified nodule than in patients with no calcified nodules, along with more ThCFAs (but not more VH-TCFAs) and more necrotic core plaque and dense calcium. These findings suggested that calcified nodules might be a marker for atherosclerosis; however, they were associated with fewer future cardiac events, suggesting quiescence rather than ongoing activity.
Axial Distribution of Calcified Nodules
Angiographic and VH Features of Calcified Nodule
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